We’re currently experiencing extremely high call volumes. We’re very sorry for any inconvenience this might cause.

If you need help with your account, please visit our Help Centre, or email us and we’ll get back to you as soon as we can. For more information and tips on managing your account online please visit www.hl.co.uk/coronavirus

We’re experiencing high call volumes, please check FAQs before calling.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Polar Capital Global Healthcare Trust plc (PCGH) Ordinary 25p Shares

Sell:190.00p Buy:193.00p 0 Change: 5.00p (2.68%)
Market closed Prices as at close on 30 March 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 5.00p (2.68%)
Market closed Prices as at close on 30 March 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 5.00p (2.68%)
Market closed Prices as at close on 30 March 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Trade high:
Year high:
Estimated NAV:
Previous close:
Trade low:
Year low:
0.50p (0.27%)
Dividend yield:
Data delayed by at least 15 minutes.


  • Net Asset Value (NAV)
POLAR CAP GLBL performance chart


POLAR CAP GLBL performance chart
Full interactive share price and premium / discount charts


1 week 1W 13.72% 1 year 1Y 10.98%
1 month 1M 18.56% 2 years 2Y 1.91%
3 months 3M 22.61% 3 years 3Y 7.67%
6 months 6M 14.84% 5 years 5Y 6.42%

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Trust Basics

Benchmark: MSCI ACWI/Health Care GR USD
Annual management charge: 0.85% of Net Assets
Performance fee: Yes
Ongoing charge: 1.13%
Dividend yield: 1.11%
Dividend frequency: Semi-Annually
Total assets: £300m
Gross gearing: 113%
Market capitalisation:Market cap.: £227m
Shares in issue: 121.27 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB00B6832P16

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents


The investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks across all four healthcare sub-sectors, being pharmaceuticals, biotechnology, medical technology and healthcare services.


Estimated NAV: 214.79
Latest actual NAV: 214.24
Latest actual NAV date: 25 March 2020
Premium/Discount: -14.35%
12m average Premium/Discount: -8.42%
NAV frequency: Daily

Recent trade data is temporarily unavailable. We will be replacing it shortly, however in the meantime the information is available on the London Stock Exchange website.

Security Weight
GlaxoSmithKline plc Ordinary 25p 4.64%
Becton, Dickinson and Co 4.15%
Bristol-Myers Squibb Company 3.88%
Zimmer Biomet Holdings Inc 3.64%
Ucb S.a. NPV (CDI) 3.50%
Smith & Nephew plc Ordinary USD0.20 3.39%
Bio-Rad Laboratories Inc 3.38%
Varian Medical Systems Inc 3.33%
HCA Healthcare Inc 3.32%
Cigna Corp 3.31%
Sector Weight
Healthcare 105.49%
Country Weight
United States 74.73%
United Kingdom 11.12%
Denmark 5.10%
Japan 3.57%
Belgium 3.50%
Spain 3.18%
Germany 2.72%
Canada 1.58%

Key Dates

Launch date: 15 June 2010
Financial year end: September
Next AGM: February 2021
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.